/
BDMD
$1.14+$0.08 (+7.55%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$33.9M
32M shares
52-week range
$0.76 – $4.72
10% from low
Exchange
NASDAQ
CS
Borrow rate
56.42%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-4.86
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $12.2M | $18.1M | $27.7M | $35.1M | $31.5M | $37.0M | $22.5M |
| Cost of revenue | $1.3M | $2.5M | $4.5M | $7.1M | $4.2M | $4.4M | $3.7M |
| Gross profit | $10.9M | $15.6M | $23.2M | $28.0M | $27.2M | $32.7M | $18.9M |
| Gross margin | 89.4% | 86.1% | 83.6% | 79.9% | 86.6% | 88.2% | 83.8% |
| R&D | $1.2M | $750.5K | $1.0M | $3.9M | $4.3M | $6.2M | $20.1M |
| Operating income | $5.6M | $9.9M | $11.9M | $13.6M | $11.9M | $15.3M | −$25.5M |
| EBITDA | $5.8M | $10.3M | $14.2M | $16.3M | $12.9M | $16.2M | −$24.5M |
| Net income | −$7.2M | $7.1M | $11.7M | $12.6M | $10.5M | $12.5M | −$27.3M |
| Net margin | -58.8% | 39.2% | 42.1% | 35.8% | 33.5% | 33.6% | -121.0% |
| EPS (diluted) | -1.00 | 0.99 | -0.02 | 0.02 | 0.41 | 0.49 | -0.98 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$2.78
Price
$1.14
Implied upside
+144%
Peer comparison
Baird Medical Investment Holdings Ltd Ordinary Share
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
- Employees
- 146
- IPO / List date
- Oct 2, 2024
Held by traders on TradeandTell
No one on the platform currently holds BDMD.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BDMD as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BDMD yet.
